Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.Lynne Mofenson, Russell Van Dyke, Michael T. Brady et al.|PubMed Central|2009Cited by 226
Treating Opportunistic Infections among HIV-Exposed and Infected Children: Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of AmericaLynne Mofenson, Cathy Wilfert, Leslie Serchuck et al.|Clinical Infectious Diseases|2005Cited by 139
Long-term Safety and Efficacy of a Once-Daily Regimen of Emtricitabine, Didanosine, and Efavirenz in HIV-Infected, Therapy-Naive Children and Adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021Ross E. McKinney, Mobeen H. Rathore, Jack Rodman et al.|PEDIATRICS|2007Cited by 47
Treating Opportunistic Infections Among HIV-Exposed and Infected Children: Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of AmericaLynne Mofenson, Cathy Wilfert, James M. Oleske et al.|PsycEXTRA Dataset|2004Cited by 45
Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countriesRohan Hazra, Sonia Stoszek, Laura Freimanis Hance et al.|International Journal of Epidemiology|2008Cited by 27